Metformin Does Not Enhance Insulin-stimulated Vasodilation in Skeletal Muscle Resistance Arteries of the OLETF Rat

Overview

Journal Microcirculation

Specialties Biology
Cardiology & Vascular Diseases

Date 2013 Jul 25

PMID 23879830

Citations 6

Authors

Jacqueline M Crissey

Jaume Padilla

Nathan T Jenkins

Jeffrey S Martin

Randy Scott Rector

John P Thyfault

Maurice Harold Laughlin

Affiliations

Soon will be listed here.

Abstract

Objective: To test the hypothesis that chronic metformin treatment enhances insulin-induced vasodilation in skeletal muscle resistance arteries and arterioles.

Methods: We assessed the effect of metformin treatment (from 20 to 32 weeks of age) of obese Otsuka Long Evans Tokushima Fatty (OLETF) rats and lean LETO rats (300 mg/kg) on insulin-stimulated vasodilation in isolated skeletal muscle feed arteries and arterioles.

Results: Metformin treatment significantly lowered food intake, body weight, percent body fat, and HbA1c in OLETF rats. Metformin resulted in a ~30% reduction in insulin-induced vasodilation of soleus feed arteries (SFA) from OLETF rats. Inhibition of endothelin-1 (ET-1) signaling produced 20% dilation and eliminated the difference between metformin-treated and untreated OLETF rats in insulin-induced dilation of SFA. In contrast to the SFA, metformin did not alter insulin-stimulated vasodilation in gastrocnemius feed arteries (GFA), or second-order arterioles in the red (G2A-R) or white (G2A-W) portions of the gastrocnemius muscle of OLETF rats. Metformin had no effects on vasomotor responses of arteries from LETO.

Conclusions: Although metformin exerts favorable effects on body composition and HbA1c, it does not enhance the vasodilatory responses to insulin in the skeletal muscle feed arteries or arterioles of the obese OLETF rat.

Citing Articles

Persistent insulin signaling coupled with restricted PI3K activation causes insulin-induced vasoconstriction.

Olver T, Grunewald Z, Ghiarone T, Restaino R, Sales A, Park L Am J Physiol Heart Circ Physiol. 2019; 317(5):H1166-H1172.

PMID: 31603345 PMC: 6879917. DOI: 10.1152/ajpheart.00464.2019.

Exercise and Vascular Insulin Sensitivity in the Skeletal Muscle and Brain.

Olver T, Laughlin M, Padilla J Exerc Sport Sci Rev. 2019; 47(2):66-74.

PMID: 30883470 PMC: 6424136. DOI: 10.1249/JES.0000000000000182.

Microvascular insulin resistance in skeletal muscle and brain occurs early in the development of juvenile obesity in pigs.

Olver T, Grunewald Z, Jurrissen T, MacPherson R, LeBlanc P, Schnurbusch T Am J Physiol Regul Integr Comp Physiol. 2017; 314(2):R252-R264.

PMID: 29141949 PMC: 5867673. DOI: 10.1152/ajpregu.00213.2017.

A chronic physical activity treatment in obese rats normalizes the contributions of ET-1 and NO to insulin-mediated posterior cerebral artery vasodilation.

Olver T, McDonald M, Klakotskaia D, Richardson R, Jasperse J, Melling C J Appl Physiol (1985). 2017; 122(4):1040-1050.

PMID: 28183819 PMC: 5407197. DOI: 10.1152/japplphysiol.00811.2016.

Transcriptomic effects of metformin in skeletal muscle arteries of obese insulin-resistant rats.

Padilla J, Thorne P, Martin J, Rector R, Akter S, Davis J Exp Biol Med (Maywood). 2017; 242(6):617-624.

PMID: 28114814 PMC: 5685263. DOI: 10.1177/1535370216689825.

References

Eringa E, Stehouwer C, Roos M, Westerhof N, Sipkema P . Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats. Am J Physiol Endocrinol Metab. 2007; 293(5):E1134-9. DOI: 10.1152/ajpendo.00516.2006. View

Iida K, Kawakami Y, Suzuki M, Shimano H, Toyoshima H, Sone H . Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats. Am J Physiol Endocrinol Metab. 2003; 284(6):E1125-30. DOI: 10.1152/ajpendo.00430.2002. View

Kim J, Montagnani M, Kon Koh K, Quon M . Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006; 113(15):1888-904. DOI: 10.1161/CIRCULATIONAHA.105.563213. View

Vincent M, Montagnani M, Quon M . Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep. 2003; 3(4):279-88. DOI: 10.1007/s11892-003-0018-9. View

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

Majithiya J, Balaraman R . Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. Life Sci. 2005; 78(22):2615-24. DOI: 10.1016/j.lfs.2005.10.020. View

Kubota T, Kubota N, Kumagai H, Yamaguchi S, Kozono H, Takahashi T . Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab. 2011; 13(3):294-307. DOI: 10.1016/j.cmet.2011.01.018. View

DeFronzo R, Barzilai N, Simonson D . Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab. 1991; 73(6):1294-301. DOI: 10.1210/jcem-73-6-1294. View

Laye M, Rector R, Warner S, Naples S, Perretta A, Uptergrove G . Changes in visceral adipose tissue mitochondrial content with type 2 diabetes and daily voluntary wheel running in OLETF rats. J Physiol. 2009; 587(Pt 14):3729-39. PMC: 2742294. DOI: 10.1113/jphysiol.2009.172601. View

10.

Baron A, Steinberg H, Chaker H, LEAMING R, Johnson A, Brechtel G . Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest. 1995; 96(2):786-92. PMC: 185264. DOI: 10.1172/JCI118124. View

11.

Wu M, Johnston P, Sheu W, Hollenbeck C, Jeng C, Goldfine I . Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care. 1990; 13(1):1-8. DOI: 10.2337/diacare.13.1.1. View

12.

Wallis M, Wheatley C, Rattigan S, Barrett E, Clark A, Clark M . Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats. Diabetes. 2002; 51(12):3492-8. DOI: 10.2337/diabetes.51.12.3492. View

13.

Kirpichnikov D, McFarlane S, Sowers J . Metformin: an update. Ann Intern Med. 2002; 137(1):25-33. DOI: 10.7326/0003-4819-137-1-200207020-00009. View

14.

Panunti B, Kunhiraman B, Fonseca V . The impact of antidiabetic therapies on cardiovascular disease. Curr Atheroscler Rep. 2005; 7(1):50-7. DOI: 10.1007/s11883-005-0075-4. View

15.

Towler M, Grahame Hardie D . AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 2007; 100(3):328-41. DOI: 10.1161/01.RES.0000256090.42690.05. View

16.

Abbasi F, Carantoni M, Chen Y, Reaven G . Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Diabetes Care. 1998; 21(8):1301-5. DOI: 10.2337/diacare.21.8.1301. View

17.

Clark M, Wallis M, Barrett E, Vincent M, Richards S, Clerk L . Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab. 2003; 284(2):E241-58. DOI: 10.1152/ajpendo.00408.2002. View

18.

Hother-Nielsen O, Schmitz O, Andersen P, Beck-Nielsen H, Pedersen O . Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. Acta Endocrinol (Copenh). 1989; 120(3):257-65. DOI: 10.1530/acta.0.1200257. View

19.

Baron A, Clark M . Role of blood flow in the regulation of muscle glucose uptake. Annu Rev Nutr. 1997; 17:487-99. DOI: 10.1146/annurev.nutr.17.1.487. View

20.

Laughlin M, Woodman C, Schrage W, Gute D, Price E . Interval sprint training enhances endothelial function and eNOS content in some arteries that perfuse white gastrocnemius muscle. J Appl Physiol (1985). 2003; 96(1):233-44. DOI: 10.1152/japplphysiol.00105.2003. View